AzurRx BioPharma Initiates Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

These long term observation data could indicate that niclosamide treatment has the potential to improve long haul COVID-19 symptoms.